In this study, the lack of differentiation between clinical groups when IFN-γ-producing CMV-specific T cells were used as markers for predicting CMV reactivation also suggests that the T cell immune response at the level of one cytokine alone is too simplistic to assess the risk of CMV infection. This evidence concerns the gene IFNG and cytomegalovirus infection.